urokinase-type plasminogen activator
Showing 1 - 25 of >10,000
Esophagus Cancer, Adenocarcinoma Trial in Copenhagen (uPAR immunohistochemistry)
Completed
- Esophagus Cancer, Adenocarcinoma
- uPAR immunohistochemistry
-
Copenhagen, Region Hovedstaden, DenmarkRigshospitalet
Jun 1, 2021
Soluble Urokinase-type Plasminogen Activator Receptor in
Recruiting
- Severe Aortic Stenosis or Severe Aortic Regurgitation
-
Seoul, Korea, Republic ofDivision of Cardiology, Severance Cardiovascular Hospital, Yonse
Nov 26, 2020
Melatonin, Soluble Urokinase-type Plasminogen Activator
Unknown status
- Preterm Premature Rupture of Membranes
- Obstetric ultrasound and fetal-maternal assessment
-
Gaziantep, TurkeyCengiz Gokcek Women's and Children's Hospital
Oct 8, 2020
Initial Investigation of Patients With Suspected Pneumonia
Active, not recruiting
- Pneumonia, Bacterial
- PCT
- +2 more
-
Aabenraa, DenmarkHospital of Southern Jutland
Apr 19, 2022
Ischemic Stroke, Acute Trial (Recombinant Human tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA), Best Medical
Not yet recruiting
- Ischemic Stroke, Acute
- Recombinant Human tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA)
- Best Medical Management
- (no location specified)
Nov 24, 2022
SuPAR in Adult Patients With Covid-19
Completed
- Covid19
- Soluble Urokinase Plasminogen Activator Receptor
-
Larissa, Thessaly, GreeceUniversity Hospital of Larisa, Department of Anesthesiology
Oct 16, 2021
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR
Not yet recruiting
- Pericarditis
- IL1RA Antibody Assay
- suPAR Testing
-
Homburg, Germany
- +8 more
Jun 22, 2023
Plasma Soluble Urokinase Plasminogen Activator Receptor and
Not yet recruiting
- Behçet Disease
- (no location specified)
Jan 11, 2021
The Role of Ischemia Modified Albumin in Patients With COVID-19
Recruiting
- COVID-19
- Ischemia Modified Albumin
-
Larissa, Thessalia, GreeceLarissa University Hospital
May 4, 2022
Acute Ischemic Stroke Trial (rhTNK-tPA, Antiplatelet Agents)
Not yet recruiting
- Acute Ischemic Stroke
- rhTNK-tPA
- Antiplatelet Agents
- (no location specified)
Mar 1, 2023
Soluble Urokinase Plasminogen Activator Receptor in Non-cardiac
Completed
- Surgery--Complications
- Soluble Urokinase Plasminogen Activator Receptor
-
Larisa, Thessaly, GreeceUniversity Hospital of Larisa, Department of Anesthesiology
Nov 11, 2020
Septic Shock, Sepsis, Severe Trial in Izmir (suPAR)
Completed
- Septic Shock
- Sepsis, Severe
- suPAR
-
İzmir, TurkeyEge University School of Medicine
Jul 6, 2020
International Study of Inflammation in COVID-19
Recruiting
- Covid19
- +4 more
- SuPAR, C-reactive protein, Ferritin, D-Dimer, Procalcitonin, Interleukin-6, Lactate Dehydrogenase
-
Ann Arbor, MichiganUniversity of Michigan
Aug 17, 2022
End-stage Heart Failure Trial in Bron (HeartMate 3 TM Left Ventricular Assist System, Guideline Directed Medical Therapy)
Recruiting
- End-stage Heart Failure
- HeartMate 3 TM Left Ventricular Assist System
- Guideline Directed Medical Therapy
-
Bron, FranceHôpital Pneumologique et Cardiovasculaire Louis Pradel
May 17, 2022
Ischemic Stroke, Acute Trial in Beijing (rhTNK-tPA ( 0.25 mg/kg, Max 25 mg ), standard medical treatment)
Recruiting
- Ischemic Stroke, Acute
- rhTNK-tPA ( 0.25 mg/kg, Max 25 mg )
- standard medical treatment
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital, Capital Medical University
Jan 29, 2022
Transgenderism, Clotting Disorder Trial in Milwaukee (Estradiol Tablets, Transdermal patch)
Terminated
- Transgenderism
- Clotting Disorder
- Estradiol Tablets
- Transdermal patch
-
Milwaukee, WisconsinFroedtert Hospital
Dec 19, 2022
Biomarkers in Acute High-risk AbdoMinAl Surgery
Completed
- General Surgery
- +3 more
- Emergency abdominal surgery
-
Hvidovre, Capital Region, DenmarkHvidovre University hospital
Aug 4, 2022
Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown Trial in Liverpool (Alteplase)
Recruiting
- Acute Respiratory Failure
- +2 more
-
Liverpool, New South Wales, AustraliaIntensive Care Unit, Liverpool Hospital, South Western Sydney Lo
Sep 15, 2022
Hematoma, Subdural, Fibrinolytic; Hemorrhage Trial in Hamilton (Tissue Plasminogen Activator, Placebo)
Not yet recruiting
- Hematoma, Subdural
- Fibrinolytic; Hemorrhage
- Tissue Plasminogen Activator
- Placebo
-
Hamilton, Ontario, CanadaHamilton General Hospital
Aug 4, 2022
Stroke, Acute Ischemic Trial (Tissue Plasminogen Activator (Alteplase))
Not yet recruiting
- Stroke, Acute Ischemic
- Tissue Plasminogen Activator (Alteplase)
- (no location specified)
Aug 16, 2022
AOrtic Surgery: Systemic Inflammatory Response Versus Sepsis
Recruiting
- Systemic Inflammatory Response Syndrome
- +4 more
- Blood sample test
- Thoracic Aortic Surgery
-
Hradec Králové, Královehradecký Kraj, CzechiaUniversity Hospital Hradec Králové
Aug 31, 2023